Long-term stability of clinical-grade lentiviral vectors for cell therapy.

Autor: Jadlowsky JK; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA., Leskowitz R; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA., McKenna S; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA., Karar J; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA., Ma Y; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA., Dai A; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA., Plesa G; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA., Chen F; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA., Alexander K; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA., Petrella J; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA., Gong N; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA., Hwang WT; Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA 19104, USA., Farrelly O; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA., Barber-Rotenberg J; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA., Christensen S; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA., Gonzalez VE; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA., Chew A; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA., Fraietta JA; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., June CH; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.; Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.; Parker Institute for Cancer Immunotherapy at the University of Pennsylvania, Philadelphia, PA 19104, USA.

Publikováno v: Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2024 Jan 10; Vol. 32 (1), pp. 101186. Date of Electronic Publication: 2024 Jan 10 (Print Publication: 2024).

In-silico analysis predicts disruption of normal angiogenesis as a causative factor in osteoporosis pathogenesis.

Autor: James, Remya^1,2 (AUTHOR) remyajames@stjosephscollegeforwomen.ac.in, Subramanyam, Koushik Narayan³ (AUTHOR), Payva, Febby^1,2 (AUTHOR), E, Amrisa Pavithra¹ (AUTHOR), TV, Vineeth Kumar⁴ (AUTHOR) vineethkumartv@thecochincollege.edu.in, Sivaramakrishnan, Venketesh⁵ (AUTHOR), KS, Santhy² (AUTHOR) santhy_zoo@avinuty.ac.in

Publikováno v: BMC Genomic Data. 10/8/2024, Vol. 25 Issue 1, p1-23. 23p.

Therapeutic Drug Monitoring for Sirolimus in Children with Vascular Anomalies: What Can We Learn from a Retrospective Study.

Autor: Hu, Ya-Hui¹ (AUTHOR), Zhao, Yue-Tao^1,2 (AUTHOR), Guo, Hong-Li¹ (AUTHOR), Li, Yue¹ (AUTHOR), Zhang, Yuan-Yuan¹ (AUTHOR), Wang, Jie¹ (AUTHOR), Ding, Xuan-Sheng² (AUTHOR), Zou, Ji-Jun³ (AUTHOR) zoujijun1979@njmu.edu.cn, Chen, Feng¹ (AUTHOR) zoujijun1979@njmu.edu.cn

Publikováno v: Pharmaceuticals (14248247). Oct2024, Vol. 17 Issue 10, p1255. 15p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Xanthoxylin Attenuates Lipopolysaccharide-Induced Lung Injury through Modulation of Akt/HIF-1α/NF-κB and Nrf2 Pathways.

Autor: Liu, Fu-Chao^1,2 (AUTHOR) ana5189@cgmh.org.tw, Yang, Yuan-Han³ (AUTHOR) b0105023@cgmh.org.tw, Liao, Chia-Chih^1,2 (AUTHOR) m7147@cgmh.org.tw, Lee, Hung-Chen^1,2 (AUTHOR) m7079@cgmh.org.tw

Publikováno v: International Journal of Molecular Sciences. Aug2024, Vol. 25 Issue 16, p8742. 14p.